öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÂ޳зæ
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º54

ËùÊôԺУ£º¹ãÖÝÒ½¿Æ´óѧ
ËùÊôԺϵ£º
Ö°³Æ£º
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÄÚ¿Æѧ
Ñо¿ÁìÓò£º ÐÄÔàÖع¹µÄ»úÖÆÓë·ÀÖΡ£
Ñо¿ÁìÓò£º ÐÄÔàÖع¹µÄ»úÖÆÓë·ÀÖΡ£ [ÊÕÆð]




¸öÈ˼òÊö :
Â޳з棬ÄУ¬1976Äê9Ô³öÉú£¬¼®¹áºþ±±£¬2010Äê6Ô±ÏÒµÓÚ¹ãÖÝҽѧԺ£¬»ñҽѧ²©Ê¿Ñ§Î»¡£ÏÖΪ¹ãÖÝÒ½¿Æ´óѧ¸½ÊôµÚ¶þÒ½ÔºÐÄÄڿƸ±Ö÷ÈÎҽʦ¡¢Ë¶Ê¿Ñо¿Éúµ¼Ê¦¡£¼æÈι㶫ʡҽѧ»áÐÄѪ¹Ü²¡Ñ§·Ö»áµÚ¾Å½ìίԱ»áÇàÄêίԱ»áίԱ¡¢¹ã¶«Ê¡Ò½Ê¦Ð­»áÐÄÔàÖØ֢ҽʦ¹¤×÷ίԱ»áµÚÒ»½ìίԱ»áίԱ¡£¼æÈΡ¶ÑªË¨ÓëֹѪѧ¡·µÚÎå½ì±àÉóίԱ»á³£Îñ±àί¡£?¹¤×÷Çé¿ö£º±ÏÒµºó´ÓÊÂÐÄѪ¹ÜÄÚ¿ÆÁÙ´²¡¢½Ìѧ¡¢¿ÆÑй¤×÷¡£Éó¤ÓÚ¹ÚÐIJ¡½éÈëÕïÁÆ¡£Ñо¿·½ÏòΪÐÄÔàÖع¹µÄ»úÖÆÓë·ÀÖΡ£Ä¿Ç°£¬Ö÷³Ö»ò²ÎÓëÍê³É¹ú¼Ò¡°863¡±¼Æ»®×Ó¿ÎÌâ¡¢¹ãÖÝÊпƼ¼¹¥¹Ø¼Æ»®ÏîÄ¿¡¢¹ã¶«Ê¡×ÔÈ»¿Æѧ»ù½ðÏîÄ¿¸÷1ÏÏÖÖ÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿¡¢¸ßµÈѧУ²©Ê¿Ñ§¿ÆµãרÏî¿ÆÑлù½ðÁªºÏ×ÊÖúÏîÄ¿¡¢¹ã¶«Ê¡×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿¡¢¹ãÖÝÊÐÊô¸ßУ¿ÆÑмƻ®Ò»°ãÏîÄ¿¸÷1Ïî¡£·¢±íSCIÊÕ¼ÂÛÎÄ6ƪ¡£²ÎÓë±àдרÖø4²¿¡£½üÆÚ·¢±íµÄÂÛÎÄ£º1.ZhangZH,LiJ,LiuBR,LuoCF,DongQ,ZhaoLN,ZhongY,ChenWY,ChenMS,LiuSM.MicroRNA-26wasdecreasedinratcardiachypertrophymodelandmaybeapromisingtherapeutictarget.JCardiovascPharmacol.2013;62(3):312-319.2.LuoCF,HouN,TianJ,YuanM,LiuSM,XiongLG,LuoJD,ChenMS.Metabolicprofileofpuerarininratsafterintragastricadministrationofpuerarinsolidlipidnanoparticles.IntJNanomedicine,2013,8:933-940.3.LuoCF,CaiB,HouN,YuanM,LiuSM,JiH,XiongLG,XiongW,LuoJD,ChenMS.UDP-glucuronosyltransferase1A1istheprincipalenzymeresponsibleforpuerarinmetabolisminhumanlivermicrosomes.ArchToxicol.2012,86(11):1681-1690.4.LuoCF,YuanM,ChenMS,LiuSM,HuangBY,LiuXW,ZhuL.Determinationofpuerarininratplasmabyrapidresolutionliquidchromatographytandemmassspectrometryinpositiveionizationmode.JChromatogrBAnalytTechnolBiomedLifeSci,2011,879(19):1497-1501.5.LuoCF,YuanM,ChenMS,LiuSM,ZhuL,HuangBY,LiuXW,XiongW.Pharmacokinetics,tissuedistributionandrelativebioavailabilityofpuerarinsolidlipidnanoparticlesfollowingoraladministration.IntJPharm,2011,410(1-2):138-144.6.LuoCF,YuanM,ChenMS,LiuSM,JiH.Metabolitesofpuerarinidentifiedbyliquidchromatographytandemmassspectrometry:similarmetabolicprofilesinliverandintestineofrats.JChromatogrBAnalytTechnolBiomedLifeSci,2010,878(3-4):363-370.?ÅàÑøÌõ¼þ£º¹ãÖÝÒ½¿Æ´óѧ¸½ÊôµÚ¶þÒ½ÔºÐÄÄڿƱ»ÆÀΪ¹ã¶«Ê¡ÖصãÁÙ´²×¨¿Æ¡¢¹ãÖÝÊÐÖصãѧ¿Æ£¨ÐÄѪ¹Ü²¡ÓëÐÄѪ¹ÜÒ©Àí£©£¬ÐÄÄÚ¿Æ×÷ΪÁÙ´²Ò½Ñ§Ò»¼¶Ñ§¿ÆµÄÖØÒª×é³É²¿·ÖÈëÑ¡¹ã¶«Ê¡ÅÊ·åÖصãѧ¿Æ£¬ÐÄÄÚ¿ÆÉèÁ¢¶ÀÁ¢µÄÐĵ¼¹ÜÊÒ£¬Ôڹ㶫ʡÄÚ½ÏÔ翪չÐÄѪ¹Ü¼²²¡µÄ½éÈëÖÎÁÆ£¬ÔÚ½éÈëÐÄÔಡѧ¡¢ÐÄѪ¹ÜΣ¼±ÖØÖ¢µÄ¾ÈÖεȷ½Ãæ»ýÀÛÁ˷ḻµÄÁÙ´²¾­Ñé¡£¹ãÖÝÐÄѪ¹Ü¼²²¡Ñо¿ËùÐÄѪ¹ÜʵÑéÊÒÊǹãÖÝÊÐÖصãʵÑéÊÒ£¬½¨Á¢ÁËÐÄѪ¹Ü¹¦ÄÜÑо¿Æ½Ì¨¡¢µ°°××éѧÑо¿Æ½Ì¨µÈ£¬ÎªÐÄѪ¹Ü¿ÆѧÑо¿ÌṩÁËÁ¼ºÃµÄ¹²ÏíµÄ¿ÆÑÐƽ̨¡£???